The legalization and proliferation of an commercially-offered implanted brain chip, especially one that interfaced with the notoriously vital hypothalamus, was met with public outcry and legislative difficulty, to the surprise of no one. However, the surprise over the speed with which that public outcry and legislative difficulty drained away was